15 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 32863923 | TLR9 induces colitis-associated colorectal carcinogenesis by regulating NF-κB expression levels. | 2020 Oct | 1 |
2 | 32935491 | Chloroquine Treatment Suppresses Mucosal Inflammation in a Mouse Model of Eosinophilic Chronic Rhinosinusitis. | 2020 Nov | 1 |
3 | 30572800 | Cell-Free DNA Release by Mouse Fetal Membranes. | 2019 Jun | 2 |
4 | 28884630 | Fetal and Placental DNA Stimulation of TLR9: A Mechanism Possibly Contributing to the Pro-inflammatory Events During Parturition. | 2018 May | 1 |
5 | 24725889 | Microglial activation mediates host neuronal survival induced by neural stem cells. | 2014 Jul | 4 |
6 | 24859061 | Therapeutic potential of chloroquine in a murine model of inflammatory bowel disease. | 2014 Aug | 2 |
7 | 22544937 | TLR9 provokes inflammation in response to fetal DNA: mechanism for fetal loss in preterm birth and preeclampsia. | 2012 Jun 1 | 1 |
8 | 22595112 | Cytidine-phosphate-guanosine oligonucleotides induce interleukin-8 production through activation of TLR9, MyD88, NF-κB, and ERK pathways in odontoblast cells. | 2012 Jun | 1 |
9 | 22659438 | Targeting Toll-like receptors by chloroquine protects mice from experimental cerebral malaria. | 2012 Aug | 1 |
10 | 20628022 | A Toll-like receptor 9-mediated pathway stimulates perilipin 3 (TIP47) expression and induces lipid accumulation in macrophages. | 2010 Oct | 1 |
11 | 18305095 | Chloroquine and inhibition of Toll-like receptor 9 protect from sepsis-induced acute kidney injury. | 2008 May | 5 |
12 | 18602491 | Role of bacterial DNA in macrophage activation by group B streptococci. | 2008 Aug-Sep | 1 |
13 | 17521621 | TLR2 synergizes with both TLR4 and TLR9 for induction of the MyD88-dependent splenic cytokine and chemokine response to Streptococcus pneumoniae. | 2007 Feb | 1 |
14 | 16148144 | Th1-like cytokine induction by heat-killed Brucella abortus is dependent on triggering of TLR9. | 2005 Sep 15 | 1 |
15 | 14996414 | Chloroquine protects mice from challenge with CpG ODN and LPS by decreasing proinflammatory cytokine release. | 2004 Feb | 1 |